More on CAPR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $8.64 |
|
|||
| Open | $8.58 | ||||
| 52 Wk High | $5.40 | ||||
| 52 Wk Low | $1.88 | ||||
| Day High | $8.70 | ||||
| Day Low | $8.23 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,396,226 | ||||
- Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
- Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
- Piper Sandler Upgrades Capricor Therapeutics (CAPR) to Overweight 'Ahead of Extended 11/22 PDUFA Date'
- Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
- Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
- Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
- Oppenheimer Upgrades Capricor Therapeutics (CAPR) to Outperform 'on Approval Optimism'
- Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
- Increasing unusual put volume: CAPR EYPT WPM ROST CBRG LNC FVRR IOT IOVA PR BNTX TEVA HWM MRNA BLSH BMNU
- FDA extends Capricor deramiocel review to November 22, HC Wainwright comments
Entities mentioned with CAPR
- FDA | View Related Stories »
- Twitter | View Related Stories »
- S3 | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
